Peginterferon alfa-2b: all 135 studies that test it
Page 2 of 2. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide VaccineCompletedNCT00861406Phase 1
- Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)TerminatedNCT00811967Phase 3
- Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 PatientsTerminatedNCT00803309Phase 4
- Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)CompletedNCT00787371Phase 2
- A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced MelanomaStatus unknownNCT00746746Phase 2
- PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)CompletedNCT00724620Phase 4
- The Role of Dendritic Cells in Hepatitis C InfectionCompletedNCT00723242Not applicable
- Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid TumorsTerminatedNCT00701298Phase 1
- Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic MelanomaCompletedNCT00623402Phase 2
- CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's LymphomaCompletedNCT00574730Not applicable
- Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)TerminatedNCT00511121Phase 2
- Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4CompletedNCT00502099Phase 4
- Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis CCompletedNCT00418054Phase 2
- Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)WithdrawnNCT00381017Phase 3
- A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder SubjectsCompletedNCT00367887Phase 2
- Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol TherapyCompletedNCT00351871Phase 4
- Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00351403Phase 4
- A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis CStatus unknownNCT00332176Phase 2
- Chronic Hepatitis C Non-Responder Study With AdoMet and BetaineCompletedNCT00310336Phase 2/3
- PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CMLCompletedNCT00303290Phase 1
- Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve SubjectsCompletedNCT00299936Phase 3
- PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By SurgeryCompletedNCT00276523Phase 2
- PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic MelanomaCompletedNCT00238329Phase 2
- PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)CompletedNCT00221702Phase 3
- PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin TherapyCompletedNCT00215865Phase 3
- Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non RespondersTerminatedNCT00122629Phase 3
- PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube CancerTerminatedNCT00085384Phase 1/2
- Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid TumorsCompletedNCT00055809Phase 2
- PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney CancerCompletedNCT00045279Phase 2
- PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or IntronTerminatedNCT00037882Phase 2
- Phase III PEG-Intron in HIV-infected Patients (Study P00738)CompletedNCT00035360Phase 3
- Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV CoinfectionCompletedNCT00015652Not applicable
- Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid TumorsCompletedNCT00014261Phase 1
- Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive ChildrenCompletedNCT00006325Phase 1
- Safety and Effectiveness of PEG-Intron in HIV-Infected PatientsCompletedNCT00005012Phase 2